Cargando…
Anti‐PD‐1 therapy plus chemotherapy showed superior and durable survival benefit in a patient with small cell esophageal cancer: A case report
The prognosis of the small cell esophageal cancer (SCEC) patient in our study was poor due to lack of treatment options which were limited to surgery and chemotherapies, with a median overall survival (OS) of only 11.1 months according to previous studies. Herein, we adopted the regimen of immunothe...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812062/ https://www.ncbi.nlm.nih.gov/pubmed/33174677 http://dx.doi.org/10.1111/1759-7714.13735 |